Skip to main content

Table 1 Risk of asthma, recurrent wheeze and bronchial hyperreactivity with various metrics of environmental tobacco smoke

From: Cotinine versus questionnaire: early-life environmental tobacco smoke exposure and incident asthma

 

2 years

7 years

 

Recurrent wheeze

Asthma

Bronchial hyperreactivity

 

Yes

No

Adjusted* OR#

Yes

No

Adjusted OR

Yes

No

Adjusted OR

Measures at 3rd trimester/birth

Maternal smoking (self-reported) during 3rd trimester

5/23 (21.7)

18/252 (7.1)

3.5 (1.2,10.7) p=0.025

4/50 (8.0)

19/229 (8.3)

0.5 (0.1,1.6)

11/146 (7.5)

9/112 (8.0)

0.9 (0.4,2.3)

Any family member smoking (self-reported) during 3rd trimester

11/23 (47.8)

60/252 (23.8)

2.9 (1.2,7.0) p=0.015

14/50 (28.0)

58/229 (25.3)

0.9 (0.4,1.9)

38/146 (26.0)

29/112 (25.9)

1.0 (0.6,1.8)

Cord blood cotinine above 50th percentile

16/23 (69.6)

119/252 (47.2)

2.6 (1.0,6.5) p=0.045

31/50 (62.0)

106/229 (46.3)

1.7 (0.9,3.2)

74/146 (50.7)

51/112 (45.5)

1.2 (0.7,2.0)

Measures at 12 months

Maternal smoking (self-reported) at 12 months

4/33 (12.1)

29/332 (8.7)

1.3 (0.4,4.1)

5/71 (7.0)

28/299 (9.4)

0.3 (0.1,1.0)

15/188 (8.0)

15/150 (10.0)

0.8 (0.4,1.7)

Any family member smoking (self-reported) at 12 months

10/33 (30.3)

66/332 (19.9)

1.7 (0.8,3.8)

15/71 (21.1)

62/299 (20.7)

0.7 (0.3,1.4)

45/188 (23.9)

27/150 (18.0)

1.5 (0.9,2.7)

 

Urinary cotinine:Cr above 50th percentile at 12 months

23/33 (69.7)

167/332 (50.3)

2.2 (0.99,4.7)

43/71 (60.6)

149/299 (49.8)

1.2 (0.7,2.1)

94/188 (50.0)

79/150 (52.7)

0.9 (0.6,1.3)

  1. BOLD indicates p < 0.05 frequency of exposure at given age amongst those with (“yes”) or without (“no”) given diagnosis.
  2. * each model adjusted for group allocation (“intervention”) and for any baseline characteristic (race gender, history of asthma, maternal education, residence city, season, child’s atopic status) with p<0.05 upon being entered in a stepwise manner.
  3. # odds of having given respiratory condition amongst those with given ETS exposure relative to those without such ETS exposure (95% CI).